在AML中解码白血病干细胞:从识别到有针对性的根除
Elisavet Apostolidou1, Vasileios Georgoulis1, Dimitrios Leonardos1
1Department of Haematology, University Hospital of Ioannina, 45 500 Ioannina, Greece.
白血病干细胞 (LSCs) 驱动急性髓性白血病 (AML) 复发. 了解LSC生物学和向这些耐治疗细胞对于改善AML治疗结果和预防疾病复发至关重要.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 干细胞研究 干细胞研究
背景情况:
- 由于复发率高,急性髓性白血病 (AML) 存在重大治疗挑战.
- 白血病干细胞 (LSCs) 是一种罕见的,耐治疗的群体,负责疾病的重新开始和复发.
研究的目的:
- 审查LSC生物学最近的进展,重点关注与正常造血干细胞 (HSC) 的功能和表型差异.
- 讨论LSC量化方法,潜在的分子程序以及当前/新兴的治疗策略.
- 检查转化障碍,并提出将LSC评估纳入临床实践的框架.
主要方法:
- 目前关于LSC生物学,功能和治疗向的文献综合.
- 讨论多参数流细胞计和标记面板用于LSC量化.
- 对LSC中信号传递,代谢和表观遗传失调的审查.
主要成果:
- 与HSC相比,LSC表现出不同的功能和表型特征.
- 调节失调的细胞程序有助于LSC的持续性和可测量的残留疾病.
- 目前正在研究针对LSC的各种治疗策略,以及已识别的转化障碍.
结论:
- 针对LSC是克服AML治疗挑战和降低复发率的关键.
- 需要进一步的研究和测试协调,以有效地将LSC评估纳入AML管理.
- 开发新的LSC导向疗法有望改善AML患者的治疗结果.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Lineage Commitment
